abstracts

0
Rate this post

Feuillet précédente

Abstracts Lille 2003

Étalon commencement Judas N° Symposium N°contagion Auteurs Règlement Adresses
Aposter Lundi 14/04   P21 C Victorri-Littorine (1); D Oliveira (1); M Bourin (1); P Jolliet (1); RISK PERCEPTION AND PHARMACOVIGILANCE SELF MEDICATION : AN OPINION SURVEY DROWN ON CONSUMERS AND PHARMACISTS
Abstract comble
(1) Épicentre Siège de Pharmacovigilance, Institution de Génétique 9 embarcadère Moncousu, NANTES;
Aposter Lundi 14/04   P22 M Bronnec (1); B Guitton (2); M Bourin (1); P Jolliet (1); METABOLIC DISTURBANCES ASSOCIATED WITH ATYPICAL ANTIPSYCHOTICS
Abstract comble
(1) Épicentre Siège de Pharmacovigilance, Institution de Génétique 9 embarcadère Moncousu, NANTES; (2) Largesse de Psychiatrie Hospitalo-Professeur, Hosto Séraphin Jacques – CHU, NANTES;
Aposter Lundi 14/04   P23 M Bronnec (1); E Lolarge (2); R Bocher (2); M Bourin (1); P Jolliet (1); CLOZAPINE-INDUCED NEUTROPHILIA : A RARE HEMATOLOGICAL SIDE-EFFECT
Abstract comble
(1) Épicentre Siège de Pharmacovigilance, Institution de Génétique 9 embarcadère Moncousu, NANTES; (2) Largesse de Psychiatrie V, Hosto Séraphin Jacques – CHU, NANTES;
Aposter Lundi 14/04   P24 A Chiffoleau (1); D Drui (2); G Veyrac (1); Y Cariou (1); JM Chavigny (3); B Milpied (4); M Bourin (1); P Jolliet (1); ALLERGY TO BETA BLOCKERS OR ALLERGY REVEALED BY BETA BLOCKERS ? CASE REPORT AND ITS ALLERGIC CROSS REACTION THERAPEUTIC MANAGEMENT
Abstract comble
(1) Épicentre Siège de Pharmacovigilance, Institution de Génétique 9 embarcadère Moncousu, NANTES; (2) Maternité cardiologique et des maladies vasculaires, CHU, NANTES; (3) Épicentre Médicinal Sud Loire Mauvoisins, Rue Mauvoisins, NANTES; (4) Largesse de Dermatologie, CHU, NANTES;
Aposter Lundi 14/04   P25 A Chiffoleau (1); T Ponge (2); G Veyrac (1); F Pajot (1); J Barrier (2); M Bourin (1); P Jolliet (1); HYDROXYCARBAMIDE (HYDREA®) AND GEANT NECROTIC ULCERATIONS IN AN OLD THROMBOCYTEMIC PATIENT
Abstract comble
(1) Épicentre Siège de Pharmacovigilance, Institution de Génétique 9 embarcadère Moncousu, NANTES; (2) Largesse de Allopathie Dedans, CHU, TOULOUSE;
Aposter Lundi 14/04   P26 CH Ben Salem (1); J Michot (1); V Pras (1); S Makki (1); M Biour (1); DRUG-INDUCED ACUTE PANCREATITIS: AN UPDATED DATABASE
Abstract comble
(1) Épicentre Siège de Pharmacovigilance, Hosto Séraphin-Antoine, PARIS;
Aposter Lundi 14/04   P27 G Mounier (1); C Guy (1); MN Beyens (1); M Ratrema (1); M Ollagnier (1); FLURBIPROFEN-INDUCED ACUTE RENAL FAILURERESULTS OF THE FRENCH POST-MARKETING SURVEILLANCE
Abstract comble
(1) Épicentre de Pharmacovigilance, CHU Séraphin-Etienne Bellevue, SAINT-ETIENNE;
Aposter Lundi 14/04   P28 G Durrieu (1); E Gorsse (1); J Montastruc (1); NEWSPAPERS : SOURCE OF INFORMATION ABOUT DOPING IN SPORTS
Abstract comble
(1) Largesse de Pharmacologie Maternité, Hôpital Méd de Heurt Dopage, Institut de Allopathie, TOULOUSE;
Aposter Lundi 14/04   P29 G Veyrac (1); F Briec (2); A Chiffoleau (1); H Villain (1); H Le Marec (2); M Bourin (1); P Jolliet (1); DILATED CARDIOMYOPATHY AFTER CHRONIC TREATMENT WITH TRICYCLIC ANTIDEPRESSANT DRUGS
Abstract comble
(1) Épicentre Siège de Pharmacovigilance, Institution de Génétique 9 embarcadère Moncousu, NANTES; (2) Maternité cardiologique et des maladies vasculaires, CHU, NANTES;
Aposter Lundi 14/04   P30 G Veyrac (1); MT Legall (2); A Chiffoleau (1); M Bourin (1); P Jolliet (1); PROLONGED BLEEDING TIME BY PAROXETINE (DEROXAT®)
Abstract comble
(1) Épicentre Siège de Pharmacovigilance, Institution de Génétique 9 embarcadère Moncousu, NANTES; (2) Survenue R.Rolland, Rézé, REZE;
Aposter Lundi 14/04   P31 T Trenque (1); F Cardona (1); A Molia (1); H Millart (1); ML Prussien (1); INTRADISCAL CALCIFICATION WITH INTRADISCAL INJECTION OF GLUCOCORTICOIDS
Abstract comble
(1) Épicentre Siège de Pharmacovigilance, Épicentre Empressé Professeur, REIMS;
Aposter Lundi 14/04   P32 A Molia (1); A Delcourt (2); MA Preiss (2); ML Prussien (1); T Trenque (1); EPOETIN : A DOSE-DEPENDENT MARKED THROMBOCYTOSIS ?
Abstract comble
(1) Épicentre Siège de Pharmacovigilance, Épicentre Empressé Professeur, REIMS; (2) Largesse de Cardiologie, Épicentre Empressé, SAINT-DIZIER;
Aposter Lundi 14/04   P33 F Cardona (1); G Jolimoy (2); C Kreft-Jaïs (2); T Trenque (1); IMPROVING REPORTING OF ADVERSE EVENTS RELATED TO ANTICANCER DRUGS TREATMENT
Abstract comble
(1) Épicentre Siège de Pharmacovigilance, Épicentre Empressé Professeur, REIMS; (2) Conformité de Pharmacovigilance, AFSSAPS, SAINT DENIS;
Aposter Lundi 14/04   P34 AP Jonville-Bera (1); F Tauveron (1); L Bensouda (1); F Délicat-Salinas (1); E Autret-Leca (1); EXTRAPYRAMIDAL REACTIONS FROM CURRENT SSRI AND NEUROLEPTIC USE
Abstract comble
(1) Épicentre Siège de Pharmacovigilance, CHRU, TOURS;
Aposter Lundi 14/04   P35 M Ollagnier (1); P Caton (2); B Trombert (3); C Guy (1); P Beck (2); GASTROINTESTINAL HAEMORRHAGES AND NSAIDS : A PROSPECTIVE STUDY
Abstract comble
(1) Épicentre de Pharmacovigilance, CHU Séraphin-Etienne Bellevue, SAINT-ETIENNE; (2) URCAM-CPAM de St-Etienne, 3 Chemin du Directeur Emile Loubet, SAINT-ETIENNE; (3) Largesse de Personnalité Manifeste (S.S.P.I.M.), Hosto de Séraphin-Pantalon-Bonnefonds, SAINT-JEAN-BONNEFONDS;
Aposter Lundi 14/04   P36 I Heran (1); MP Pépite (1); H Peyriere (1); D Hillaire-Buys (1); JP Blayac (1); TWO CASES OF GYNECOMASTIA IN CHILDREN TREATED WITH CETIRIZINE, A SECOND GENERATION ANTIHISTAMINE
Abstract comble
(1) Largesse de Pharmacologie Médicale et Toxicologie, Hosto Lapeyronie, MONTPELLIER;
Aposter Lundi 14/04   P37 J Micallef (1); S Tardieu (1); K Khalech (1); O Blin (1); BENZODIAZEPINE AND HICCUPS : THREE CASE REPORTS
Abstract comble
(1) CPCET & Largesse de Pharmacologie Maternité, CHU Timone, MARSEILLE;
Aposter Lundi 14/04   P38 O Maillard (1); C Guy (1); M Burellier (2); MN Beyens (1); M Ratrema (1); G Mounier (1); D Michel (3); M Ollagnier (1); REVERSIBLE DEMENTIA ASSOCIATED WITH VALPROIC ACID MONOTHERAPY
Abstract comble
(1) Épicentre Siège de Pharmacovigilance, CHU Séraphin-Etienne Bellevue, SAINT-ETIENNE; (2) 11 Chemin de la glèbe, , CRAPONNE SUR ARZON; (3) Largesse de Neurologie, CHU Séraphin-Etienne Bellevue, SAINT-ETIENNE;
Aposter Lundi 14/04   P39 V Pinzani (1); D Hillaire-Buys (1); S Petit (2); H Peyrière (1); N Mirfendereski (1); JP Blayac (1); ETONOGESTREL AND HEMORRHAGIC STROKE: A CASE REPORT
Abstract comble
(1) Largesse de Pharmacologie Médicale et Toxicologie, Hosto Lapeyronie, MONTPELLIER; (2) Diocèse de Allopathie Corporel et Réinsertion, Hosto Caremeau, NIMES;
Aposter Lundi 14/04   P40 C Cabou (1); H Bagheri (1); A Cantagrel (2); B Mazière (2); JL Montastruc (1); RETROSPECTIVE ANALYSIS OF ADVERSE REACTIONS OF INFLIXIMAB IN A DEPARTMENT OF RHUMATOLOGY
Abstract comble
(1) Largesse de Pharmacologie Maternité, Institut de Allopathie-CHU, TOULOUSE; (2) Largesse de Rhumatologie, CHU Rangueil, TOULOUSE;
Aposter Lundi 14/04   P41 ML Hemery (1); V Pinzani (1); P Quittet (2); V Faucherre (3); C Janbon (4); JP Blayac (1); THROMBOEMBOLIC COMPLICATIONS AND INTERFERON ALFA 2B THERAPY
Abstract comble
(1) Pharmacologie Médicale et Toxicologie, Hosto Lapeyronie, MONTPELLIER; (2) Hématologie, Hosto Lapeyronie, MONTPELLIER; (3) Allopathie F, Hosto Séraphin-Eloi, MONTPELLIER; (4) Allopathie B, Hosto Séraphin-Eloi, MONTPELLIER;
Aposter Lundi 14/04   P42 P Lochet (1); V Faucherre (2); V Pinzani (1); ML Hemery (1); D Hillaire Buys (1); JP Blayac (1); REVERSIBLE INSULIN-DEPENDENT DIABETES MELLITUS ASSOCIATED WITH INTERFERON THERAPY IN A CHRONIC HEPATITIS C PATIENT
Abstract comble
(1) Pharmacologie Médicale et Toxicologie, Hosto Lapeyronie, MONTPELLIER; (2) Allopathie Dedans F, Hosto Séraphin Eloi, MONTPELLIER;
Aposter Lundi 14/04   P43 N Mirfendereski (1); P Lochet (1); A Gauthey-abderrahim (1); V Pinzani (1); D Hillaire-Buys (1); JP Blayac (1); LAUROMACROGOL AND TRANSIENT NEUROLOGIC DISORDERS
Abstract comble
(1) Largesse de Pharmacologie, Hosto Lapeyronie, MONTPELLIER;
Aposter Lundi 14/04   P44 ML Laroche (1); F Macian-Montoro (2); L De Lumley (3); M Amaniou (1); M Lacoste (2); L Montagnard (1); CEREBRAL ISCHEMIA AND ISOTRETINOIN : TWO CASE REPORTS
Abstract comble
(1) Épicentre Siège de Pharmacovigilance, CHU Dupuytren, LIMOGES; (2) Largesse de Neurologie, CHU Dupuytren, LIMOGES; (3) Diocèse de Pédiatrie Médicale, CHU Dupuytren, LIMOGES;
Aposter Lundi 14/04   P45 C Lafay (1); C Bottier (1); C Remblier (1); MC Perault (1); NON CONFORMITY IN PHARMACOVIGILANCE
Abstract comble
(1) Largesse de Pharmacologie Maternité-CRPV, CHU, POITIERS;
Aposter Lundi 14/04   P46 D Raylet (1); C Lafay (1); S Favreliere (1); B Dreyfus (2); MC Perault (1); RABEPRAZOLE INDUCED ERYTHEMA NODOSUM
Abstract comble
(1) Largesse de Pharmacologie Maternité-CRPV, CHU, POITIERS; (2) Largesse d’Hématologie de Judas, CHU, POITIERS;
Aposter Lundi 14/04   P47 L Chauvelot-Moachon (1); M De Menton (2); S Abad (2); C Vauzelle (1); F Bavoux (1); P Terreuse (2); TRAMADOL, WITH THE ANTIDEPRESSANTS INHIBITORS OF SEROTONIN REUPTAKE, INDUCE A SEROTONIN SYNDROME
Abstract comble
(1) Pharmacovigilance, Institut de Allopathie et Hosto Cochin, PARIS; (2) Allopathie Dedans, Hosto Cochin, PARIS;
Aposter Lundi 14/04   P48 C Remblier (1); G Desprairies (2); C Lafay (1); MC Perault (1); ORIGINAL ANGIOGRAPHIC PATTERN AND EDEMA RELATED TO METHYSERGIDE
Abstract comble
(1) CRPV-Largesse de Pharmacologie Maternité, CHU, POITIERS; (2) Allopathie-Phlébologie, Désintéressé, LA ROCHELLE;
Aposter Lundi 14/04   P49 V Corpulent-Champel (1); H Masson (1); C Lematte (1); P Pakula (1); B Roussel (2); K Masmoudi (1); M Andréjak (1); ASSESSMENT OF ORAL ANTICOAGULATION MANAGEMENT QUALITY AMONG PATIENTS ADMITTED TO THE AMIENS UNIVERSITY HOSPITAL
Abstract comble
(1) Pharmacovigilance Épicentre, CHU Amiens Sud, AMIENS; (2) Haematology laboratory, CHU Amiens Arctique, AMIENS;
Aposter Lundi 14/04   P50 C Remblier (1); C Pradère (2); S Favrelière (1); MC Perault (1); POSSIBLE SEROTONIN SYNDROME ASSOCIATED WITH FLUOXETINE AND HYDROMORPHONE COADMINISTRATION
Abstract comble
(1) CRPV-Largesse de Pharmacologie Maternité, CHU, POITIERS; (2) Prophylaxie de Conclusion D, CHU, POITIERS;
Aposter Lundi 14/04   P51 AC Resende (1); S Faure (1); S Nadaud (2); I Lartaud-Idjouadiène (1); J Atkinson (1); C Capdeville-Atkinson (1); MELATONIN ATTENUATES THE DECREASE IN NORADRENALINE (NA)-INDUCED CONTRACTION OF RAT AORTIC RINGS PRODUCED BY PROLONGED INCUBATION
Abstract comble
(1) EA 3448, Institut de Ampoule, NANCY; (2) INSERM 525, 91 bd de l’Hosto, PARIS;
Aposter Lundi 14/04   P52 A Rupin (1); J R Paysant (1); T J Verbeuren (1); ANOXIA/REOXYGENATION AND AN INFLAMMATORY CONTEXT SYNERGISTICALLY INCREASE E-SELECTIN EXPRESSION THROUGH NADPH OXIDASE IN HUVECS
Abstract comble
(1) Fragment Phlébologie, Institution de Simulation Servier, SURESNES;
Aposter Lundi 14/04   P53 K Chalupsky (1); I Lobysheva (2); G Entlicher (3); F Nepveu (2); JC Stoclet (1); B Muller (4); N-HYDROXYLATED COMPOUNDS AS SUBSTRATES FOR NO PRODUCTION IN BLOOD VESSELS
Abstract comble
(1) Pharmacologie et Physicochimie, CNRS UMR 7034, Institut de Ampoule, Internat Pépite Pâtre, ILLKIRCH; (2) Pharmacophores Redox Phytochimie & Radiobiologie, EA-3030, Institut de Ampoule, Internat Paul Sabatier, TOULOUSE; (3) Departement of Biochemistry, Charles University, PRAGUE, TCHEQUIE; (4) Pharmacologie INSERM EMI 9937, Institut de Ampoule, Internat Victor Segalen, BORDEAUX;
Aposter Lundi 14/04   P54 P Guerard (1); O Barthez (1); F Goirand (2); L Rochette (1); JP Dumas (1); M Dumas (1); M Bardou (1); THE HMG-COA REDUCTASE INHIBITOR, PRAVASTATIN, PREVENTS THE DEVELOPMENT OF MONOCROTALINE-INDUCED PULMONARY HYPERTENSION IN THE RAT
Abstract comble
(1) LPPCE, Institut de allopathie, DIJON; (2) Cabinet de Physiologie, Institut de ampoule, CHATENAY-MALABRY;
Aposter Lundi 14/04   P55 J Paysant (1); A Rupin (1); P Sansilvestri-Morel (1); N Lembrez (1); T Verbeuren (1); ANOXIA/REOXYGENATION INDUCED A NADPH OXIDASE DEPENDENT OXIDATIVE STRESS IN ENDOTHELIAL CELLS WHICH OVEREXPRESSED E-SELECTIN VIA NFKB ACTIVATION
Abstract comble
(1) Fragment Phlébologie, Institution de Simulation Servier, SURESNES;
Aposter Lundi 14/04   P56 S Simonet (1); C Badier Décréter (1); J R Paysant (1); C Vayssettes Courchay (1); A Rupin (1); Y Menant (1); C Hennape (1); G Gautier (1); T J Verbeuren (1); EFFECTS OF NADH AND NADPH IN RABBIT AORTA : SIGNALLING PATHWAY AND COMPARISON WITH EFFECTS NOTED IN RABBIT SAPHENOUS VEIN
Abstract comble
(1) Fragment Phlébologie, Institution de Simulation Servier, SURESNES;
Aposter Lundi 14/04   P57 F Pourageaud (1); V Leblais (1); R Marthan (2); B Muller (1); PHENOXYBENZAMINE PRE-TREATMENT REVEALS AN ATYPICAL BETA-ADRENERGIC RELAXATION IN RAT INTRAPULMONARY ARTERIES
Abstract comble
(1) Cabinet Pharmacologie, INSERM EMI9937, Institut de Ampoule, BORDEAUX; (2) Cabinet de Physiologie, INSERM EMI9937, Institut de Allopathie, BORDEAUX;
Aposter Lundi 14/04   P58 N Ryckelynck (1); C Laurent (1); R Morello (2); B Mosquet (1); J Lacotte (1); E Singlas (3); A Coquerel (1); OBSERVATIONAL STUDY ABOUT GENERIC DRUGS USE IN BASSE NORMANDIE (ACHIEVED DURING 2001) AMONG FIVE HUNDRED GENERAL PRACTITIONERS
Abstract comble
(1) Pharmacovigilance, CHU, CAEN; (2) Infographie Medicale, CHU, CAEN; (3) Chimie Médical, Institut de Ampoule, Internat de Caen, CAEN;
Aposter Lundi 14/04   P59 A Umar (1); F Depont (1); A Backgammon (1); S Lignot (1); B Bégaud (1); MC Segur (2); M Boisseau (3); N Moore (1); EFFECTS OF ARMAGNAC OR VODKA ON PLATELET AGGREGATION IN HEALTHY VOLUNTEERS: A RANDOMIZED CLINICAL TRIAL
Abstract comble
(1) Pharmacologie, Internat Victor Segalen Amarante 2, BORDEAUX; (2) BNIA, EAUZE; (3) Hématologie, CHU Amarante, BORDEAUX;
Aposter Lundi 14/04   P60 M Billing-Grima (1); J Anjuere (1); J Steger (1); C Bourdenet-Coquard (1); JL Imbs (2); RELATION BETWEEN PLASMA ANGIOTENSIN II AND TISSUE INTERNALIZATION VIA THE AT1 RECEPTOR
Abstract comble
(1) Institution de Pharmacologie, Institut de Allopathie Internat Pépite Pâtre, STRASBOURG; (2) Largesse de Maladies Vasculaires, Hypertesion et Pharmacologie asile, Asiles Universitaires de Strasbourg, STRASBOURG;
Aposter Lundi 14/04   P61 M Barthelmebs (1); N Wiernsperger (2); JR Rapin (3); M Grima (4); JL Imbs (4); METFORMIN ACCUMULATION IN THE KIDNEY OF DIABETIC RATS DOES NOT ALTER RENAL FUNCTION NOR WORSEN IT DURING ACUTE RENAL FAILURE
Abstract comble
(1) INSERM E0015, Institut de Allopathie, STRASBOURG; (2) Merck-Lipha, 37 rue Séraphin-Latin, LYON; (3) Dospharma, 3 rue du Tronquet, MONT SAINT AIGNAN; (4) Institution de Pharmacologie, Institut de Allopathie, STRASBOURG;
Aposter Lundi 14/04   P62 M Diebolt (1); L Prussien (2); F Auger (2); R Andriantsitohaina (1); HUMAN TISSUE-ENGINEERED VASCULAR MEDIA AS A PHARMACOLOGICAL TOOL TO STUDY THE REGULATION OF CONTRACTION BY POLYPHENOLS
Abstract comble
(1) UMR CNRS 7034, Institut de ampoule, ILLKIRCH; (2) Cabinet d’organogénèse incrédule, Internat de Laval, QUEBEC, CANADA;
Aposter Lundi 14/04   P63 L Guedon-Moreau (1); JL Gayet (2); Y Frances (3); M Galinier (4); H Lardoux (5); C Libersa (1); INCIDENCE OF ADVERSE EVENTS AFTER ELECTRICAL CARDIOVERSION FOR ATRIAL FIBRILLATION IN EPCAF STUDY
Abstract comble
(1) Pharmacologie, CHRU LILLE, LILLE; (2) -, COLOMBES; (3) Cardiologie, Hosto Arctique, MARSEILLE; (4) Cardiologie, CHU Rangueil, TOULOUSE; (5) Cardiologie, Troupe Empressé Sud Francilien, CORBEIL ESSONNES;
Aposter Lundi 14/04   P64 S Davani (1); A Marandin (2); N Mersin (3); B Royer (1); H Reyssie (1); B Kantelip (4); JP Kantelip (1); MESENCHYMAL PROGENITOR CELLS DIFFERENTIATE TO AN ENDOTHELIAL PHENOTYPE, ENHANCE VASCULAR DENSITY AND IMPROVE HEART FUNCTION IN A RAT CELLULAR CARDIOMYOPLASTY MODEL
Abstract comble
(1) Pharmacologie-EA479, CHU Pantalon Minjoz, BESANÇON; (2) EFS-EA2284, Etablissement Hexagonal du Lignage, BESANÇON; (3) Acte Cardiovasculaire et Thoracique-EA479, CHU Pantalon Minjoz, BESANÇON; (4) Anatomopathologie-EA479, CHU Pantalon Minjoz, BESANÇON;
Aposter Lundi 14/04   P65 JS Hulot (1); JL Démolis (1); R Torrent (1); S Strabach (1); S Christin-Maitre (2); C Funck-Brentano (1); ABSENCE OF INFLUENCE OF ENDOGENOUS ESTROGENS ON QT INTERVAL DURATION
Abstract comble
(1) Épicentre d’sondage asile, Hosto Séraphin-Antoine, PARIS; (2) Largesse d’Endocrinologie, Hosto Séraphin-Antoine, PARIS;
Aposter Lundi 14/04   P66 A Umar (1); M Boisseau (2); MC Segur (3); N Moore (1); EFFECT OF AGE OF ARMAGNAC EXTRACT AND DURATION OF TREATMENT ON ANTITHROMBOTIC EFFECTS IN A RAT THROMBOSIS MODEL
Abstract comble
(1) Pharmacologie, Internat Victor Segalen Amarante 2, BORDEAUX; (2) Hématologie, Internat Victor Segalen Amarante 2, BORDEAUX; (3) BNIA, EAUZE;
Aposter Lundi 14/04   P67 P Philip-Couderc (1); A Pathak (1); F Smih (1); JM Senard (1); X Traquenard (2); F Quatrain (2); M Galinier (1); P Verwaerde (1); J Roncalli (1); T Castillo (1); P Rouet (1); HIGH FAT DIET INDUCES SYNTHESIS OF A NEW CARDIAC SECRETED PROTEIN THAT IS DETECTED IN HDL3
Abstract comble
(1) INSERM U317, Institut de Allopathie, Largesse de Pharmacologie, TOULOUSE; (2) INSERM U563, CHU Purpan, TOULOUSE;
Aposter Lundi 14/04   P68 P Philip-Couderc (1); F Smih (1); A Pathak (1); JM Senard (1); M Galinier (1); P Vervaerde (1); J Roncalli (1); P Massabuau (1); T Castillo (1); P Rouet (1); A NEW CARDIAC HOMEOPROTEIN INDUCED BY NUTRITIONAL OBESITY
Abstract comble
(1) INSERM U317, Institut de Allopathie, Largesse de Pharmacologie, TOULOUSE;
Aposter Lundi 14/04   P69 C Arnaud (1); M Satisfait-Faure (1); D Godin-Ribuot (1); JL Cracowski (1); C Ribuot (1); HEAT STRESS TRIGGERS PROTEIN KINASE C EPSILON TRANSLOCATION AND HSP27 PHOSPHORYLATION
Abstract comble
(1) Cabinet Anoxie Physio-Pathologie, Institut de Ampoule, GRENOBLE;
Aposter Lundi 14/04   P70 C Barel (1); M Belkhiria (2); B Bui-Xuan (3); J Descotes (1); PH Noble (4); MC Gagnieu (5); F Arnal (1); P Tsibiribi (1); Q Timour (1); HEMODYNAMIC AND CARDIAC ELECTROPHYSIOLOGICAL EFFECTS OF ROPIVACAINE COMBINED WITH VARIOUS ANTIARRHYTHMIC DRUGS IN THE PIG
Abstract comble
(1) Cabinet de Pharmacologie Médicale, Internat Claude Bernard, LYON; (2) Cabinet de Pharmacologie, Internat de Monastir, MONASTIR, TUNISIE; (3) Diocèse d’Narcose Anesthésiologie, Hosto Edouard Herriot, LYON; (4) Largesse de Cardiologie, Hosto Pépite Pradel, BRON; (5) Cabinet de Biochimie, Hosto Edouard Herriot, LYON;
Aposter Lundi 14/04   P71 N Ripoll (1); DJ David (1); MC Colombel (1); M Hascoët (1); M Bourin (1); ANTIDEPRESSANT-LIKE EFFECTS IN VARIOUS MICE STRAINS IN THE TAIL SUSPENSION TEST
Abstract comble
(1) EA 3256 Neurobiologie de l’fébrilité et de la abattement, Institut de Allopathie, NANTES;
Aposter Lundi 14/04   P72 JM Reymann (1); G Bantsiele (1); M Bourin (2); EFFECT OF MILNACIPRAN COMPARED TO REFERENCE COMPOUNDS ON POST-STROKE EMOTIONAL DISTURBANCES, ASSESSED IN ANIMAL MODELS OF DEPRESSION OR ANXIETY
Abstract comble
(1) EA 3256 Neurobiologie de l’fébrilité et de la abattement, Largesse de Pharmacologie Maternité et Expérimentale, RENNES; (2) EA 3256 Neurobiologie de l’fébrilité et de la abattement, Institut de Allopathie, NANTES;
Aposter Lundi 14/04   P73 BA Nic Dhonnchadha (1); M Hascoët (1); P Jolliet (1); M Bourin (1); ANXIOLYTIC-LIKE PROPERTIES OF DOI: EVIDENCE FOR A 5-HT2A RECEPTOR MODE OF ACTION
Abstract comble
(1) EA 3256 Neurobiologie de l’fébrilité et de la abattement, Institut de Allopathie, NANTES;
Aposter Lundi 14/04   P74 M Boulouard (1); V Mauduit (1); V Lelong (1); D Debruyne (2); A Coquerel (2); INTERACTION BETWEEN BUPRENORPHINE AND CLORAZEPATE DIPOTASSIC ON SPONTANEOUS ACTIVITY AND ANXIETY IN THE MOUSE
Abstract comble
(1) Cabinet de pharmacologie CERMN UPRES EA 2126, Institut de Ampoule, Internat de Caen, CAEN; (2) Largesse de Pharmacologie et CEIP Arctique Ponant, CHU, CAEN;
Aposter Lundi 14/04   P76 V Bertaina-Anglade (1); E Enjuanes (1); C Drieu La Mezzanine (1); EFFECTS OF THIOPERAMIDE, AN HISTAMINE H3 ANTAGONIST ON MEMORY PERFORMANCE IN AN OBJECT RECOGNITION TASK IN C57BL6/J MICE
Abstract comble
(1) BIOTRIAL, Department of Preclinical Pharmacology, RENNES;
Aposter Lundi 14/04   P77 C Courteix (1); AM Privat (1); T Pélissier (2); A Eschalier (3); J Fialip (1); SPINAL EFFECT OF AGMATINE ON HYPERALGESIA, ALLODYNIA AND MORPHINE-INDUCED ANALGESIA IN DIABETIC RATS
Abstract comble
(1) INSERM 9904 Cabinet de Pharmacologie Médicale, Institut de Ampoule, CLERMONT-FD; (2) Department of pharmacology, Faculty of Medicine University of Chile, SANTIAGO, CHILI; (3) INSERM 9904 Cabinet de Pharmacologie Médicale, Institut de Allopathie, CLERMONT-FD;
Aposter Lundi 14/04   P78 Y Pelloux (1); J Costentin (1); D Duterte-Obstruer (1); NOVELTY SEEKING ON THE PLAYGROUND MAZE PREDICTS DRUG CONSUMPTION IN RATS
Abstract comble
(1) UMR CNRS 6036, IFRMP 23, Institut de Allopathie et de Ampoule, ROUEN;
Aposter Lundi 14/04   P79 F Loiseau (1); C Le Bihan (1); M Hamon (1); MH Thiébot (1); LACK OF EFFECTS OF MELATONIN IN TWO ANXIOGENIC CONFLICT PROCEDURES IN RATS
Abstract comble
(1) INSERM U288, Institut de Allopathie Offrande-Salpêtrière, PARIS;
Aposter Mardi 15/04   10  P110 MJ Pantalon-Pastor (1); F Rodor (1); N Nguyen (1); N Prost (1); M Boyer (1); B Gueniot (1); A Paklesa (1); M Valli (1); CALCIUM CHANNEL BLOCKERS AND PHOTOSENSITIVITY
Abstract comble
(1) Épicentre Siège de Pharmacovigilance, 249, Bd de Heureuse-Lapsus, MARSEILLE;
Aposter Mardi 15/04   10  P111 E Polard (1); P Latour (2); A Biraben (3); D Bentue-Appâter (4); O Impôt (4); H Allain (4); DRUG INDUCED ENCEPHALOPATHY IN SIX EPILEPTIC PATIENTS: TOPIRAMATE ? VALPROATE ? OR BOTH ?
Abstract comble
(1) Épicentre de Pharmacovigilance, Hosto Pontchaillou, RENNES; (2) Largesse de Neurologie, Hosto Mulassière Terreuse, BREST; (3) Largesse de Neurologie (Conformité Epilepsie), Hosto Pontchaillou, RENNES; (4) Cabinet de Pharmacologie Expérimentale et Maternité, Institut de Allopathie, RENNES;
Aposter Mardi 15/04   10  P112 E Polard (1); J Boulliat (2); F Colinot (1); D Bentue-Appâter (3); O Impôt (3); H Allain (3); MYOCLONIC ENCEPHALOPATHY: A DELETERIOUS INTERACTION BETWEEN LEVODOPA AND PROTON PUMP INHIBITORS
Abstract comble
(1) Épicentre de Pharmacovigilance, Hosto Pontchaillou, RENNES; (2) Largesse de Neurologie, Épicentre Empressé Cité en Bresse, BOURG EN BRESSE; (3) Cabinet de Pharmacologie Expérimentale et Maternité, Institut de Allopathie, RENNES;
Aposter Mardi 15/04   10  P113 B Lewden (1); T Vial (1); E Elefant (2); A Nelva (3); P Carlier (4); J Descotes (1); Afcrpv (5); LOW-DOSE METHOTREXATE AND PREGNANCY: A FRENCH PROSPECTIVE COLLABORATIVE STUDY
Abstract comble
(1) Épicentre de Pharmacovigilance, Hosto Edouard Herriot, LYON; (2) Épicentre de Renseignements sur les Agents Tératogènes, CHU Séraphin-Antoine, PARIS; (3) Institution Occidental des Génomutations, Rue Edmond Locard, LYON; (4) Épicentre de Pharmacovigilance, Hosto Fernand Widal, PARIS; (5) Annexion Française des Groupes Régionaux de Pharmacovigilance, Hosto St Charles, MONTPELLIER;
Aposter Mardi 15/04   10  P114 MA Satisfecit (1); C Escouade (2); H Bagheri (1); A Lequellec (3); F Rolland (2); JL Montastruc (1); ADVERSE EFFECTS COULD UPSET THE TREATMENT OF ALCOHOL DEPENDENCE
Abstract comble
(1) Largesse de Pharmacologie Maternité, Institut de Allopathie-CHU, TOULOUSE; (2) Largesse d’Alccologie, Asiles de Lannemezan, LANNEMEZAN; (3) Largesse Ampoule, Asiles de Lannemezan, LANNEMEZAN;
Aposter Mardi 15/04   10  P115 N Bernard (1); T Vial (1); G Bauguil (2); G Chamba (2); J Descotes (1); ADVERSE EFFECTS REPORTED BY COMMUNITY PHARMACY STUDENTS: A 6-MONTH STUDY
Abstract comble
(1) Épicentre de Pharmacovigilance, Hosto Edouard Herriot, LYON; (2) Institut de ampoule, Diocèse de Pharmacologie, LYON;
Aposter Mardi 15/04   10  P116 V Corpulent-Champel (1); H Masson (1); B Roussel (2); JM Geslin (1); K Masmoud (1); M Andréjak (1); HEPARIN-INDUCED THROMBOCYTOPENIA (HIT) : A PROPOS OF 64 OBSERVATIONS NOTIFIED TO AMIENS PHARMACOVIGILANCE CENTRE (CRPV)
Abstract comble
(1) Pharmacovigilance Épicentre, CHU Amiens Sud, AMIENS; (2) Haematology laboratory, CHU Amiens Arctique, AMIENS;
Aposter Mardi 15/04   10  P117 M Masson (1); R Lagnaoui (1); G Miremont-Salamé (1); C Roussillon (1); E Apretna (1); A Laribière (1); F Haramburu (1); DIRECT-TO-PATIENTS INFORMATION FOR DRUGS: ONE-YEAR OBSERVATIONAL STUDY
Abstract comble
(1) Épicentre Siège de Pharmacovigilance, Diocèse de Pharmacologie, CHU, Internat Victor Segalen, BORDEAUX;
Aposter Mardi 15/04   10  P118 S Kalimouttou (1); T Lobbedez (2); A Coquerel (1); J Lacotte (1); B Mosquet (1); B Hurault De Ligny (1); APHTOSIS : STUDY IN 28 RENAL TRANSPLANT RECIPIENTS TREATED BY SIROLIMUS
Abstract comble
(1) Pharmacovigilance, CHU, CAEN; (2) Urologie, CHU, CAEN;
Aposter Mardi 15/04   10  P119 S El Aïdli (1); I Rejeïbi (1); R Daghfous (1); S Trabelsi (1); MH Loueslati (1); M Lakhal (1); C Belkahia (1); SMELL DISORDERS INDUCED BY PYRAZINAMIDE
Abstract comble
(1) Largesse de barème et d’narration des modalités, Épicentre Ressortissant de Pharmacovigilance, TUNIS, TUNISIE;
Aposter Mardi 15/04   10  P120 S El Aïdli (1); I Rejeïbi (1); R Daghfous (1); S Trabelsi (1); MH Loueslati (1); M Lakhal (1); C Belkahia (1); ERYTHEMA MULTIFORME INDUCED BY ETHAMBUTOL
Abstract comble
(1) Largesse de barème et d’narration des modalités, Épicentre Ressortissant de Pharmacovigilance, TUNIS, TUNISIE;
Aposter Mardi 15/04   10  P121 F Bavoux (1); M Thierry (1); C Vauzelle -Gardier (1); L Chauvelot Moachon (1); POLYTHERAPY WITH HIGH DOSE OF PSYCHOTROPIC DRUGS DURING PREGNANCY,FETAL AND NEONATAL RISKS
Abstract comble
(1) Conformité de Pharmacovigilance, Pharmacologie Faculte de Allopathie Cochin, PARIS;
Aposter Mardi 15/04   10  P122 S El Aïdli (1); K Khiari (2); R Daghfous (1); S Trabelsi (1); T Ben Abdallah (2); MH Loueslati (1); M Ben Maïz (2); C Belkahia (1); A CASE OF SEVER LOCAL CUTANEOUS REACTIONS TO INSULIN : HUMAN INSULIN DESENSITIZATION RESULT
Abstract comble
(1) Largesse de barème et d’narration des modalités, Épicentre Ressortissant de Pharmacovigilance, TUNIS, TUNISIE; (2) Largesse de Allopathie Dedans, Hosto Charles Nicolle, TUNIS, TUNISIE;
Aposter Mardi 15/04   10  P123 C Bousquet (1); A Lillo-Le Louët (1); C Le Beller (1); G Lagier (2); PRINCIPLES OF SEMANTIC NETWORKS FOR AUTOMATED SIGNAL DETECTION IN PHARMACOVIGILANCE
Abstract comble
(1) CRPV d’HEGP, Hosto Occidental Georges Pompidou, PARIS; (2) CRPV Fernand Widal, Hosto Fernand Widal, PARIS;
Aposter Mardi 15/04   10  P124 L Lagarce (1); JM Thoulon (2); H Plauchu (3); P Lainé-Cessac (1); E Néné (4); CALCIUM CHANNEL BLOCKERS IN PREGNANCY, THE EXPERIENCE OF THE FRENCH PHARMACOVIGILANCE CENTRES
Abstract comble
(1) CRPV, Cabinet de pharmacologie CHU, ANGERS; (2) Obstétrique gynécologie, hopital Edouard Herriot drapeau K, LYON; (3) Ancestral, Guinguette-Éternel, LYON; (4) IEG, Institution Occidental des génomutations, LYON;
Aposter Mardi 15/04   10  P125 K Martin (1); S Lawson-Ayayi (2); G Miremont-Salamé (1); AM Formaggio (3); D Lacoste (3); M Dupon (3); T Schaverberke (4); P Mercié (3); JM Ragnaud (3); F Haramburu (1); F Dabis (2); SYMPTOMATIC OSTEOPENIA AND OSTEOPOROSIS IN HIV-INFECTED PATIENTS, AQUITAINE COHORT 1999 – 2002
Abstract comble
(1) Épicentre Siège de Pharmacovigilance, Diocèse de Pharmacologie, Internat Victor Segalen, CHU, BORDEAUX; (2) INSERM U330, Internat Victor Segalen Amarante 2, BORDEAUX; (3) Épicentre d’Demande et de Prophylaxie sur l’Immunodéficience Terrienne, CHU, BORDEAUX; (4) Largesse de Rhumatologie, CHU, BORDEAUX;
Aposter Mardi 15/04   10  P126 F Bentaberry (1); K Martin (2); C Dumoulin (1); J Dehais (1); F Haramburu (2); F Liefferman (3); T Schaeverbeke (1); PERIPHERAL NEUROPATHY DURING LEFLUNOMIDE TREATMENT: A REPORT OF 5 CASES
Abstract comble
(1) Largesse de Rhumatologie, CHU, BORDEAUX; (2) Épicentre Siège de Pharmacovigilance, Diocèse de Pharmacologie, Internat Victor Segalen Amarante 2, CHU, BORDEAUX; (3) Largesse de Allopathie Dedans, CH, DAX;
Aposter Mardi 15/04   10  P127 S Ginisty (1); N Grenu (2); P Eftekhari (1); M Rajad (1); G Lagier (1); DEPRESSION IN HIV-POSITIVE PATIENTS TREATED WITH EFAVIRENZ : 87 CASES RECORDED IN FRENCH PHARMACOVIGILANCE DATABASE (FROM 13/09/1999 TO 31/01/2002)
Abstract comble
(1) Épicentre Siège de Pharmacovigilance, Hosto Fernand Widal, PARIS; (2) Attention française de ordre hygiénique des produits de trempe, Bld Anatole France, ST DENIS;
Aposter Mardi 15/04   10  P128 L Laforest (1); R Harf (2); F Clouet (3); C Ségala (4); D Poizeau (4); G Pietri (1); Y Pacheco (2); E Van Cordon (1); RELATIONSHIP BETWEEN RAGWEED POLLINATION COUNTS AND DELIVERY OF ANTI ALLERGIC MEDICATION
Abstract comble
(1) Conformité de Pharmacoépidémiologie, Épicentre Empressé Professeur Lyon Sud, PIERRE-BENITE; (2) Largesse de phtisiologie, Épicentre Empressé Professeur Lyon Sud, PIERRE-BENITE; (3) Largesse Médicinal, Fourniment Naïve d’Diplôme Dommage de Lyon, LYON; (4) SEPIA Personnalité, MELRAND;
Aposter Mardi 15/04   10  P129 F Depont (1); A Abouelfath (1); E Hunsche (2); I Addra (1); T Diatta (1); A Grelaud (1); N Moore (1); THERAPEUTIC MANAGEMENT OF CHRONIC LOW BACK PAIN IN FRANCE
Abstract comble
(1) Diocèse de Pharmacologie, Internat Victor Segalen Amarante 2, BORDEAUX; (2) Merck & Co., Whitehouse Escale, NJ, USA;
Aposter Mardi 15/04   10  P130 I Lacroix (1); S Saivin (2); M Lapeyre-Mestre (1); JL Montastruc (1); C Damase-Michel (1); EFFECTS OF MATERNAL PSYCHOTROPIC USE OR ABUSE IN NEWBORNS : PRELIMINARY RESULTS OF THE PHARMACOEPIDEMIOLOGIC STUDY NENUPHAR
Abstract comble
(1) Largesse de Pharmacologie Maternité, Institut de Allopathie, TOULOUSE; (2) Cabinet de toxicologie asile, CHU, TOULOUSE;
Aposter Mardi 15/04   10  P131 N Lechevallier (1); A Avant-coureur (1); C Berr (2); INCIDENCE OF BENZODIAZEPINE USE AND FACTORS ASSOCIATED WITH SUBSEQUENT USE IN THE ELDERLY: THE EVA STUDY
Abstract comble
(1) Diocèse de Pharmacologie, Internat Victor Segalen Amarante 2, BORDEAUX; (2) INSERM EMI-9930, Hosto de la Colombière, MONTPELLIER;
Aposter Mardi 15/04   10  P132 A Avant-coureur (1); S De Bailliencourt (2); P Latry (2); C Peter (2); N Moore (1); B Bégaud (1); CHARACTERISTICS OF CELECOXIB PRESCRIPTIONS IN THE AQUITAINE REGION: DATA FROM THE REGIONAL DATABASE OF THE SECURITE SOCIALE
Abstract comble
(1) Pharmacologie Maternité, Internat Victor Segalen Amarante 2, BORDEAUX; (2) Faveur Régionale Largesse thérapeutique démonstration malaise Aquitaine, Chemin de la Jallère, BORDEAUX;
Aposter Mardi 15/04   10  P133 T Simon (1); A Chatelin (2); M Thuault (2); H Kolsky (3); P Jaillon (1); EPIFLEC : PHARMACO-EPIDEMIOLOGIC SURVEY OF FLECAINIDE TREATMENT IN A COHORT OF PATIENTS WITH ATRIAL FIBRILLATION
Abstract comble
(1) Largesse de Pharmacologie, Hosto Séraphin-Antoine, AP-HP – UP6, PARIS; (2) MEDICAWEB, 67 rue Vergniaud, PARIS; (3) 3M SANTE, Bd de l’Oise, CERGY PONTOISE;
Aposter Mardi 15/04   10  P134 N Lechevallier (1); A Avant-coureur (1); C Berr (2); PREVALENCE AND CHARACTERISTICS OF BENZODIAZEPINE USE IN THE ELDERLY: THE EVA STUDY
Abstract comble
(1) Diocèse de Pharmacologie, Internat Victor Segalen Amarante 2, BORDEAUX; (2) INSERM EMI-9930, Hosto de la Colombière, MONTPELLIER;
Aposter Mardi 15/04   10  P135 S Rambelomanana (1); E Giauque (1); R Lagnaoui (1); A Abouelfath (1); P Brochard (2); I Bois Valles (2); P Gabinski (2); B Bioulac (3); P Philip (3); N Moore (1); THE EFFECTS OF MEDICATION AND SLEEP ON WORKPLACE ACCIDENTS
Abstract comble
(1) Diocèse de Pharmacologie, Internat Victor Segalen Amarante 2, BORDEAUX; (2) Largesse de Allopathie du couches, CHU de Amarante, BORDEAUX; (3) Maternité du léthargie, CHU de Amarante, BORDEAUX;
Aposter Mardi 15/04   10  P136 M Lapeyre-Mestre (1); M Pin (1); PEDIATRIC COUNSELLING IN COMMUNITY PHARMACIES : KNOWLEDGE OF PHARMACISTS AND PHARMACY TECHNICIANS ABOUT DRUG UTILISATION IN CHILDREN
Abstract comble
(1) Largesse de Pharmacologie Maternité, Conformité de Pharmacoépidémiologie, Institut de Allopathie, TOULOUSE;
Aposter Mardi 15/04   10  P137 E Polard (1); S Belliard (2); D Bentue-Appâter (3); P Le Cavorzin (4); R Duclos (1); AG Le Guen (1); MALAISE AND LOSS OF CONSCIOUSNESS IN DEMENTED PATIENTS TREATED BY ACETYLCHOLINESTERASE INHIBITORS
Abstract comble
(1) Épicentre de Pharmacovigilance, Hosto Pontchaillou, RENNES; (2) Largesse de Neurologie, Hosto Pontchaillou, RENNES; (3) Cabinet de Pharmacologie Expérimentale et Maternité, Institut de Allopathie, RENNES; (4) Épicentre de Orthophonie Fonctionnelle, Rennes, RENNES;
Aposter Mardi 15/04   10  P138 T Ngoundo (1); M Niezborala (2); JL Montastruc (1); M Lapeyre-Mestre (1); PSYCHOACTIVE DRUG CONSUMPTION IN WORKERS AND PERFORMANCE AT WORK
Abstract comble
(1) Conformité de Pharmacoépidémiologie, Largesse de Pharmacologie Maternité, Institut de Allopathie, TOULOUSE; (2) Largesse Médicinal Inter-Sociétés, SMIT de Toulouse, TOULOUSE;
Aposter Mardi 15/04   10  P139 P Monument (1); F Pèze (1); P Cunin (2); N Elie (3); F Hemery (4); L Hittinger (5); I Masquin-Mavier (1); DRUG PRESCRIPTION AND REHOSPITALISATION RISK IN CHRONIC HEART FAILURE. LONGITUDINAL PHARMACOEPIDEMIOLOGICAL STUDY
Abstract comble
(1) Largesse Pharmacologie Maternité, Hopital Henri Mondor, CRETEIL; (2) Conformité de Simulation Maternité, Internat Paris XII, CRETEIL; (3) CPAM 94, Val de Amendement, CRETEIL; (4) Departement Demande Médicale, Hopital Henri Mondor, CRETEIL; (5) Syndicat Cardiologie, Hopital Henri Mondor, CRETEIL;
Aposter Mardi 15/04   10  P140 R Serreau (1); MF Le Heuzey (2); A Gilbert (1); YI Dubois (1); MC Mouren (2); E Jacqz-Aigrain (1); PSYCHOTROPIC MEDICATION IN CHILDREN : A FRENCH PROSPECTIVE SURVEY
Abstract comble
(1) Pharmacology Unit, Néné Debré Hospital, PARIS; (2) Psychopathology Unit, Néné Debré Hospital, PARIS;
Aposter Mardi 15/04   11  P141 G Naelten (1); B Chapuis (1); M Lo (1); J Sassard (1); LONG TERM EFFECTS OF RENIN-ANGIOTENSIN SYSTEM BLOCKADE IN GENETICALLY HYPERTENSIVE RATS OF THE LYON STRAIN (LH)
Abstract comble
(1) CNRS UMR 5014, Institut de Ampoule, LYON;
Aposter Mardi 15/04   11  P142 V Stigmate (1); M Grima (2); P Kieffer (1); C Capdeville-Atkinson (1); J Atkinson (1); I Lartaud-Idjouadiene (1); WITHDRAWAL REVEALS LACK OF EFFECT OF PROLONGED ANTIHYPERTENSIVE TREATMENT ON INTRINSIC AORTIC WALL STIFFNESS IN SENESCENT SHR
Abstract comble
(1) EA, 3448 / Institut de Ampoule, NANCY; (2) CNRS 0589, Institut de Allopathie, 11 rue Humann, STRASBOURG;
Aposter Mardi 15/04   11  P143 JL Cracowski (1); JP Baguet (2); O Ormezzano (2); J Bessard (1); F Stanke-Labesque (1); G Bessard (1); JM Mallion (2); LIPID PEROXIDATION IS NOT INCREASED IN PATIENTS WITH UNTREATED MILD TO MODERATE HYPERTENSION
Abstract comble
(1) Cabinet de Pharmacologie, Institut de Allopathie, GRENOBLE; (2) Syndicat des maladies cardio-vasculaires, CHU Grenoble, GRENOBLE;
Aposter Mardi 15/04   11  P144 I Signolet (1); P Bousquet (1); L Monassier (1); EFFECTS OF THE CENTRALLY ACTING SYMPATHOINHIBITOR, RILMENIDINE, IN 1K1C GOLDBLATT HYPERTENSIVE RABBITS
Abstract comble
(1) Cabinet de Neurobiologie et Pharmacologie Cardiovasculaire, Institut de Allopathie, STRASBOURG;
Aposter Mardi 15/04   11  P145 P Sassano (1); C Yau (1); E Ghannad (1); H Karam (1); B Fiquet (1); PROPULSION STUDY : TO ASSESS THE TOLERABILITY OF VALSARTAN (80 THEN 160 MG) IN MONOTHERAPY OVER 8 WEEKS IN HYPERTENSIVE PATIENTS AT HIGH CARDIOVASCULAR RISK
Abstract comble
(1) Novartis Pharma SAS, 2-4 rue Lionel Terray, RUEIL MALMAISON;
Aposter Mardi 15/04   11  P146 H Greney (1); D Urosevic (1); S Schann (1); L Dupuy (1); JD Ehrhardt (1); P Bousquet (1); A NEW RADIOACTIVE TOOL FOR INVESTIGATION OF I1 IMIDAZOLINE RECEPTORS
Abstract comble
(1) Cabinet de Neurobiologie et Pharmacologie Cardiovasculaire, Institut de Allopathie, STRASBOURG;
Aposter Mardi 15/04   11  P147 H Masson (1); J Varagic (2); D Susic (2); E Frohlich (2); M Andréjak (1); M Slama (1); LEFT VENTRICULAR DIASTOLIC FUNCTION : ASSESSMENT IN SPONTANEOUS HYPERTENSIVE RAT (SHR)
Abstract comble
(1) Cardiovascular physiopathology Lab, Institut de allopathie UPJV, AMIENS; (2) Ochsner Clinic Foundation, NEW ORLEANS, USA;
Aposter Mardi 15/04   11  P148 F Gueyffier (1); F Boutitie (2); JP Boissel (1); WHICH ARE THE RELEVANT QUESTIONS BEHIND THE RELATION BETWEEN A CONTINUOUS BIOMARKER AND A CLINICAL OUTCOME ? EXAMPLE OF BLOOD PRESSURE
Abstract comble
(1) Largesse de Pharmacologie Maternité, Institut RTH Laennec, LYON; (2) Largesse de Biostatistiques, Cliniques Civils de Lyon, LYON;
Aposter Mardi 15/04   12  P149 T Simon (1); M Mary-Krause (2); C Funck-Brentano (1); PH Lechat (3); P Jaillon (1); BISOPROLOL DOSE-RESPONSE RELATIONSHIP IN PATIENTS WITH CONGESTIVE HEART FAILURE
Abstract comble
(1) Largesse de Pharmacologie, Hosto Séraphin-Antoine, AP-HP – UP6, PARIS; (2) INSERM EMI-0214, Hosto Offrande-Salpétrière, PARIS; (3) Largesse de Pharmacologie, Hosto Offrande-Salpétrière, PARIS;
Aposter Mardi 15/04   12  P150 P Nony (1); E Amsallem (1); C Kasparian (1); G Haddour (1); JP Boissel (1); , For The Cardiodas Study Group (1); EVALUATION OF THE EFFECT OF PHOSPHODIESTERASE III INHIBITORS IN CHRONIC HEART FAILURE PATIENTS : AN UPDATED META-ANALYSIS
Abstract comble
(1) EA 643, Hosto Cardiologique, LYON;
Aposter Mardi 15/04   12  P151 N Mougenot (1); O Mediani (1); R Bos (1); F Brouri (1); P Lechat (1); CAPTOPRIL-FUROSEMIDE EFFECTS ON SURVIVAL ON THE EXPERIMENTAL MODEL OF HEART FAILURE IN THE RAT INDUCED BY MYOCARDIAL INFARCTION
Abstract comble
(1) IFR 14 Pharmacology Department, Offrande Salpêtrière Hospital, PARIS;
Aposter Mardi 15/04   12  P152 L Chauvelot-Moachon (1); L Fouqueray (2); C Vauzelle (1); F Bavoux (1); DOES PHARMACOLOGICAL STIMULATION OF RETINOIC ACID RECEPTORS AND RETINOID X RECEPTORS EXPOSE TO A RISK OF CARDIAC TOXICITY, AT TERM?
Abstract comble
(1) Pharmacovigilance, Institut de Allopathie et Hosto Cochin, PARIS; (2) Cardiologie, Soisy sur Gabare, SOISY;
Aposter Mardi 15/04   12  P153 P Mulder (1); V Mellin (1); A Jeng (1); JP Henry (1); C Thuillez (1); ADDTIVE EFFECTS OF TRIPLE ACE, ECE AND NEP INHIBITION ON HEMODYNAMICS, CARDIAC REMODELING AND FUNCTION IN RATS WITH CHRONIC HEART FAILURE
Abstract comble
(1) INSERM E9920, Institut de Allopathie et de Ampoule, ROUEN;
Aposter Mardi 15/04   13  P154 C Arnaud (1); JL Cracowski (1); A Hakim (1); T Durand (2); A Guy (2); D Godin-Ribuot (1); G Bessard (1); C Ribuot (1); ISOPROSTANES 15-F2T-ISOP AND 5-F2T-ISOP ARE NOT TRIGGERS OF MYOCARDIAL PRECONDITIONING
Abstract comble
(1) Cabinet de Pharmacologie, Institut de Allopathie, GRENOBLE; (2) Cabinet de Chimie Biomoléculaire et Interactions Biologiques, UMR CNRS 5074, Institut de Ampoule de Montpellier, MONTPELLIER;
Aposter Mardi 15/04   13  P155 K Aouam (1); R Tissier (1); R Souktani (1); A Berdeaux (1); B Ghaleh (1); MEASUREMENT OF POST-ISCHEMIC SYSTOLIC FUNCTION IN THE REPERFUSED HEART IN CONSCIOUS RABBITS: EFFECT OF PRECONDITIONING
Abstract comble
(1) Cabinet de Pharmacologie et INSERM E 00.01, Institut de Allopathie Paris Sud, LE KREMLIN-BICETRE;
Aposter Mardi 15/04   13  P156 T Damy (1); A Bouzamondo (1); G Montalescot (2); P Lechat (1); SUPERIOR EFFICACY OF LOW MOLECULAR WEIGHT HEPARIN VERSUS UNFRACTIONNATED HEPARIN IN ACUTE CORONARY SYNDROMES WITHOUT ST ELEVATION
Abstract comble
(1) Largesse de Pharmacologie, Hosto Offrande-Salpêtrière, PARIS; (2) Largesse de Cardiologie, Hosto Offrande-Salpêtrière, PARIS;
Aposter Mardi 15/04   13  P157 C Arnaud (1); M Satisfait (1); D Godin-Ribuot (1); JL Cracowski (1); C Ribuot (1); COX-2: AN IN VIVO EVIDENCE OF ITS PARTICIPATION TO HEAT STRESS-INDUCED MYOCARDIAL PRECONDITIONING
Abstract comble
(1) Cabinet Anoxie Physio-Pathologie, Institut de Ampoule, GRENOBLE;
Aposter Mardi 15/04   14  P158 F Blanchi (1); N Ripoll (1); DJ David (1); M Hascoët (1); M Bourin (1); AN APPROPRIATE STRATEGY FOR SCREENING ANTIDEPRESSANT DRUGS USING THE MOUSE FORCED SWIMMING TEST AND THE TAIL SUSPENSION TEST
Abstract comble
(1) EA 3256 Neurobiologie de l’fébrilité et de la abattement, Institut de Allopathie, NANTES;
Aposter Mardi 15/04   14  P159 D Tallet (1); P Del Soldato (2); M Bolla (2); N Oudart (1); NCX 950 (NO-SALBUTAMOL) SIGNIFICANTLY INHIBITS METHACHOLINE INDUCED BRONCHOCONSTRICTION AND REDUCES TACHYPHYLAXIS
Abstract comble
(1) Cabinet de Pharmacologie, Institut de Ampoule, LIMOGES; (2) Nicox SA, Talus des Dolines, SOPHIA ANTIPOLIS;
Aposter Mardi 15/04   14  P160 N Picard (1); D Ratanasavanh (2); Y Le Meur (3); A Rousseau (1); P Marquet (1); IN VITRO AND IN VIVO STUDY OF MYCOPHENOLIC ACID PHASE II METABOLISM
Abstract comble
(1) Largesse de Pharmacologie et Toxicologie, CHU, LIMOGES; (2) Cabinet de Pharmacologie, CHU Brest, BREST; (3) Largesse de urologie, CHU, LIMOGES;
Aposter Mardi 15/04   14  P161 M Molimard (1); C Raherison (2); S Lignot (1); A Abouelfath (1); F Depont (1); N Moore (1); REAL-LIFE HANDLING OF INHALER DEVICES IN 3811 PATIENTS
Abstract comble
(1) Diocèse de Pharmacologie, Internat Victor Segalen Amarante 2, BORDEAUX; (2) Largesse des Maladies Respiratoires, Hosto Élevé Lévèque, PESSAC;
Aposter Mardi 15/04   14  P162 G Ravel (1); M Christ (1); F Horand (1); J Descotes (2); EFFECT OF TWO PEDIATRIC VACCINES ON INSULIN-DEPENDENT DIABETES MELLITUS (IDDM) IN FEMALE NOD MICE
Abstract comble
(1) MDS Pharma Obligations, Les Oncins, SAINT-GERMAIN-SUR-L’ARBRESLE; (2) Impureté Center, E. Herriot Hospital, LYON;
Aposter Mardi 15/04   14  P163 M Mallem (1); V Bucas (1); F Gautier (1); M Gogny (1); J Desfontis (1); BETA3 AND ATYPICAL BETA-ADRENOCEPTORS IN HYPERTENSION
Abstract comble
(1) UPSP5304, Ecole Vétérinaire, NANTES;
Aposter Mardi 15/04   14  P164 PA Risse (1); E Naline (1); G Huchon (2); C Advenier (1); N Afrique (2); ROLE OF PAR-2 IN THE REGULATION OF AIRWAY SMOOTH MUSCLE (SM) TONE
Abstract comble
(1) UPRES EA220, UFR Biomédicale des Saints Pères, PARIS; (2) Largesse de Phtisiologie et de Anesthésiologie, Hosto de l’Guinguette Éternel, PARIS;
Aposter Mardi 15/04   14  P165 A Appert-Collin (1); A Lebon (1); P Poindron (1); JP Ges (1); CELL CYCLE REGULATORS IN MOTONEURONAL DEATH EVOKED BY NEUROTROPHIC FACTOR DEPRIVATION
Abstract comble
(1) LPCCNM, Institut de ampoule, ILLKIRCH;
Aposter Mardi 15/04   14  P166 C Pascarel (1); A- El Amrani (1); K Viaud (1); R Dalonneau (1); C Champeroux (1); S Richard (1); HERG TRANSFECTED HEK-293 CELLS: A PHARMACOLOGICAL TOOL FOR DRUG ASSESSMENT OF QT INTERVAL PROLONGATION
Abstract comble
(1) CERB, Berme de Montifault, BAUGY;
Aposter Mardi 15/04   14  P167 M Enceinte (1); O Pétrault (2); L Gruand (2); M Laprais (2); S Stolc (3); R Bordet (2); PROTECTIVE EFFECTS OF STOBADINE, AN ANTIOXIDANT AGENT, ON NEURONAL AND VASCULAR ALTERATIONS INDUCED BY ISCHEMIA/REPERFUSION (I/R) ON RAT
Abstract comble
(1) IUT A, Internat de Lille 1, VILLENEUVE D’ASCQ; (2) Cabinet de Pharmacologie, Institut de Allopathie de Lille 2, LILLE; (3) Institution de Pharmacologie Expérimentale, Corps Slovaque des Sciences, BRATISLAVA, SLOVAQUIE;
Aposter Mercredi 16/04   15  P168 C Verstuyft (1); M Schwab (2); E Schaeffeler (2); R Kerb (3); U Brinkmann (3); P Jaillon (1); C Funck-Brentano (1); L Becquemont (1); DIGOXIN PHARMACOKINETICS AND MDR1 GENETIC POLYMORPHISMS
Abstract comble
(1) Pharmacologie, Institut de allopathie Séraphin-Antoine, PARIS; (2) Dr. Margarete Fischer-Bosch-Institution für Klinische Pharmakologie, Néné Bosch foundation, STUTTGART, ALLEMAGNE; (3) Epidauros Biotechnologie, Epidauros Biotechnologie, BERNRIED, ALLEMAGNE;
Aposter Mercredi 16/04   15  P169 S Morin (1); MA Compère-loriot (2); HK Thijssen (3); A Néné (4); S Strabach (5); C Verstuyft (1); L Dubert (1); C Funck-Brentano (5); P Jaillon (1); PH Beaune (2); L Becquemont (1); VARIATIONS OF INR AND FACTOR VII ARE LINKED TO CYTOCHROME P450 2C9 GENOTYPE
Abstract comble
(1) Largesse de Pharmacologie, Institut de allopathie Séraphin-Antoine, PARIS; (2) INSERM U 490, Internat Paris V, PARIS; (3) Largesse de Pharmacologie, Internat de Maastricht, MAASTRICHT, PAYS-BAS; (4) Largesse d’coagulation, CHU Séraphin-Antoine, PARIS; (5) Épicentre d’sondage asile, CHU Séraphin-Antoine, PARIS;
Aposter Mercredi 16/04   15  P170 T Damy (1); F Pousset (2); H Caplain (3); JS Hulot (1); PH Lechat (1); PHARMACOKINETIC AND PHARMACODYNAMIC INTERACTIONS BETWEEN METOPROLOL AND DRONEDARONE IN HEALTHY SUBJECTS
Abstract comble
(1) Largesse de Pharmacologie, Hosto Offrande-Salpétrière, PARIS; (2) Largesse de Cardiologie, Hosto Offrande-Salpétrière, PARIS; (3) Aster Clinical Research Center, 3-5 rue Eugène Millon, PARIS;
Aposter Mercredi 16/04   15  P171 D Zhang (1); C Ganière-Monteil (2); Y Médard (1); M Bourin (2); E Jacqz-Aigrain (1); PHENOTYPE AND GENOTYPE FOR THIOPURINE METHYLTRANSFERASE ACTIVITY IN THE FRENCH CAUCASIAN POPULATION: IMPACT OF AGE
Abstract comble
(1) Pharmacologie Pédiatrique – Pharmacogénétique, Hosto Néné Debré, PARIS; (2) Pharmacologie, Hosto Guinguette-Éternel, NANTES;
Aposter Mercredi 16/04   15  P172 M Fakhoury (1); R Serreau (1); Y Medard (1); AL Delezoide (2); E Jacqz-Aigrain (1); REAL TIME QUANTITATIVE RT-PCR OF CYP3A IN PLACENTA
Abstract comble
(1) Pharmacology Unit, Néné Debré Hospital, PARIS; (2) Foetopathology unit, Néné Debré Hospital, PARIS;
Aposter Mercredi 16/04   15  P173 JM Poirier (1); O Zouai (1); JL Meynard (2); K Lacombe (2); PM Girard (2); P Jaillon (1); LACK OF EFFECT OF GENDER, AGE, WEIGHT AND BODY MASS INDEX ON TROUGH LOPINAVIR PLASMA CONCENTRATIONS IN HIV-EXPERIENCED PATIENTS TREATED WITH KALETRA
Abstract comble
(1) Department of pharmacology, Séraphin-Antoine University Hospital, PARIS; (2) Department of Infectious Diseases, Séraphin-Antoine Hospital, PARIS;
Aposter Mercredi 16/04   15  P174 S Laporte (1); B Tranchand (2); A Viallon (3); M Ollagnier (4); M Cucherat (5); C Guy (4); H Décousus (1); P Mismetti (1); POOLING OF INDIVIDUAL TOXICOKINETIC CASE REPORTS USING A POPULATION APPROACH MODEL
Abstract comble
(1) Conformité de Pharmacologie Maternité, EA3065, CHU Séraphin-Etienne Bellevue, SAINT-ETIENNE; (2) Épicentre Léon Bérard, Rue Laënnec, LYON; (3) Largesse d’Asile des Urgences, EA3065, CHU Séraphin-Etienne Bellevue, SAINT-ETIENNE; (4) Conformité de Pharmacologie et Toxicologie, CHU Séraphin-Etienne Bellevue, SAINT-ETIENNE; (5) EA 643 Institut RTH Laennec, Largesse de Biostatistiques, CHU Lyon, LYON;
Aposter Mercredi 16/04   15  P175 F Stanke-Labesque (1); S Larrat (1); G Bessard (1); JP Zarski (2); C Souvignet (2); RIBAVIRIN QUANTIFICATION FOR THERAPEUTIC DRUG MONITORING DURING CHRONIC HEPATITIS C COMBINATION TREATMENT
Abstract comble
(1) Cabinet de Pharmacologie, CHU Grenoble, GRENOBLE; (2) Diocèse d’hépato-gastroentérologie, CHU Grenoble, GRENOBLE;
Aposter Mercredi 16/04   15  P176 N Simon (1); G Slepchenko (2); O Pérus (2); JC Levron (3); M Raucoules-Aimé (2); B Bruguerolle (1); POPULATION PHARMACOKINETICS OF SUFENTANIL IN OBESE PATIENTS
Abstract comble
(1) Cabinet de Pharmacologie médicale et asile, Institut de allopathie, MARSEILLE; (2) Diocèse d’anesthésie-réanimation, Hosto l’Arceau 2, NICE; (3) Cabinet Janssen Cilag, Janssen Research Institution, VAL DE REUIL;
Aposter Mercredi 16/04   15  P177 N Simon (1); F Lacroix (2); E Deturmeny (1); O Paut (2); J Camboulives (2); B Bruguerolle (1); COMPARATIVE PHARMACOKINETICS OF 0.2 VS 0.375 % ROPIVACAINE DURING FASCIA ILIACA COMPARTMENT BLOCK IN CHILDREN
Abstract comble
(1) Cabinet Pharmacologie médicale et asile, Institut de allopathie, MARSEILLE; (2) Departement d’assoupissement Anesthésiologie Pédiatrique, CHU Timone, MARSEILLE;
Aposter Mercredi 16/04   15  P178 P Nony (1); JP Boissel (1); PREDICTING DRUG FORGIVENESS: A STANDARDISED GRAPHICAL APPROACH
Abstract comble
(1) EA 643, Hosto Cardiologique, LYON;
Aposter Mercredi 16/04   15  P179 E Dailly (1); M Pannier (2); P Jolliet (1); M Bourin (1); POPULATION PHARMACOKINETICS OF CEFTAZIDIME IN BURN PATIENTS
Abstract comble
(1) Cabinet de Pharmacologie, Guinguette Éternel, NANTES; (2) Largesse des Brûlés, Guinguette Éternel, NANTES;
Aposter Mercredi 16/04   15  P180 S Payen (1); R Serreau (2); A Munck (3); Y Aujard (4); Y Aigrain (5); F Bressolle (1); E Jacqz-Aigrain (2); POPULATION PHARMACOKINETICS OF CIPROFLOXACIN IN PEDIATRIC AND ADOLESCENT PATIENTS WITH ACUTE INFECTIONS
Abstract comble
(1) Clinical Pharmacokinetic Laboratory, Faculty of Pharmacy, MONTPELLIER; (2) Paediatric Pharmacology and Pharmacogenetics, Néné Debré Hospital, PARIS; (3) Gastro-Enterology, Néné Debré Hospital, PARIS; (4) Neonatologie, Néné Debré Hospital, PARIS; (5) Paediatric Surgery, Néné Debré Hospital, PARIS;
Aposter Mercredi 16/04   15  P181 C Verstuyft (1); F Marcellin (2); L Morand-Joubert (3); O Launay (4); G Peytavin (5); L Gerard (2); L Becquemont (6); JP Aboulker (2); For The Anrs 081 (7); IMPACT OF MDR1 (C3435T) GENETIC POLYMORPHISM IN PATIENTS NAÏVE TREATED WITH HAART INCLUDING INDINAVIR (IDV)
Abstract comble
(1) Pharmacology Department, Faculty of medecine, PARIS; (2) SC 10, Villejuif, VILLEJUIF; (3) Virology Department, Séraphin-Antoine Hospital, PARIS; (4) Infectious Disease Department, Bichat-Claude Bernard, PARIS; (5) Pharmacy Department, Bichat-Claude Bernard, PARIS; (6) Pharmacology Department, Séraphin-Antoine Hospital, PARIS; (7) ANRS, PARIS;
Aposter Mercredi 16/04   15  P182 X Zhang (1); V Favier (2); JM Lang (3); J Reynes (4); D Rey (3); R Rouzier-Panis (5); M Lier (2); E Gaudeul-Ehrhart (2); P Desche (2); I Patel (1); PHARMACOKINETICS OF HIV FUSION INHIBITOR T-20 (FUZEON) AFTER BOTH INTRAVENOUS (IV) AND SUBCUTANEOUS (SC) ADMINISTRATION TO HIV-1 INFECTED PATIENTS
Abstract comble
(1) Clinical pharmacology dpt, Hoffmann-La ROCHE Inc., NUTLEY, USA; (2) Institution de Pharmacologie Maternité ROCHE, Hosto Affable de Strasbourg, STRASBOURG; (3) Hôpital d’Immuno-Onco-Hematologie, Hosto Affable de Strasbourg, STRASBOURG; (4) Largesse des Maladies Infectueuses et Tropicales, Hosto Gui de Chauliac, MONTPELLIER; (5) Épicentre CAP, Maternité Rech, MONTPELLIER;
Aposter Mercredi 16/04   15  P183 E Caudron (1); V Jullien (1); C Amrein (2); R Guillemain (2); P Chevallier (2); C Le Beller (1); A Lillo-Le Louet (1); EM Billaud (1); TACROLIMUS THERAPEUTIC DRUG MONITORING (TDM) IN THE MANAGEMENT OF DRUG INTERACTION WITH VORICONAZOLE IN PULMONARY TRANSPLANTATION
Abstract comble
(1) Pharmacologie Toxicologie, HEGP, PARIS; (2) Acte Cardio Vasculaire, HEGP, PARIS;
Aposter Mercredi 16/04   15  P184 O Impôt (1); C Comprimé (2); C Arvieux (3); H Allain (1); D Bentué-Appâter (1); TACROLIMUS AND PROTEASE INHIBITORS INTERACTION IN PATIENTS WITH LIVER TRANSPLANTATION
Abstract comble
(1) Cabinet de Pharmacologie Expérimentale et Maternité, Institut de Allopathie, RENNES; (2) Largesse de Anesthésiologie Médicale, Hosto Pontchaillou, RENNES; (3) Largesse des Maladies Infectieuses, Hosto Pontchaillou, RENNES;
Aposter Mercredi 16/04   15  P185 N Ferrari (1); S Oseille (1); P Odou (2); L Kroumova (1); C Lamotte (1); J Wiart (3); P Devos (4); M Lhermitte (3); C Libersa (1); NIFEDIPINE AND GRAPEFRUIT JUICE: FACT OR FICTION ?
Abstract comble
(1) CIC Lille, CHRU LILLE, LILLE; (2) Diocèse de biopharmacie et de ampoule asile, Institut de Ampoule, LILLE; (3) Cabinet de biochimie et de génétique moléculaire, CHRU LILLE, LILLE; (4) D.I.M., CHRU LILLE, LILLE;
Aposter Mercredi 16/04   15  P186 B Guillet (1); B Bordas (1); R Purgus (2); B Dussol (2); A Durand (1); Y Berland (2); P Pisano (1); PHARMACOKINETICS OF MYCOPHÉNOLIC ACID (MPA) TOTAL AND FREE IN RENAL TRANSPLANT PATIENTS WITH CHRONIC GRAFT DYSFUNCTION
Abstract comble
(1) Syndicat de Pharmacologie, CHU Timone, 254 rue St Carrelé, MARSEILLE; (2) Largesse de Urologie, CHU Création, 170 bd Cuve, MARSEILLE;
Aposter Mercredi 16/04   15  P187 Y Hijazi (1); R Boulieu (2); CONTRIBUTION OF CYP3A4, CYP2B6, AND CYP2C9 ISOFORMS TO N-DEMETHYLATION OF KETAMINE IN HUMAN LIVER MICROSOMES
Abstract comble
(1) PDMP, Hoffmann-La Afrique, BASEL, SWITZERLAND; (2) Cabinet de Pharmacocinétique Maternité, Internat de Lyon 1, LYON;
Aposter Mercredi 16/04   16  P188 P Meshaka (1); N Mouchet (2); C Gaillez (1); S Rien (3); D Muzard (3); P Pinton (1); TREATMENT OF SEVERE SEPSIS WITH 2 ORGAN FAILURES – TEMPORARY AUTHORIZATION OF USE (TAU) OF XIGRIS IN ADULTS AND CHILDREN
Abstract comble
(1) Conformité Médical Cardiologie, Infectiologie et Anesthésiologie, Lilly France, SURESNES; (2) Diocèse des Costume Juridiques, Lilly France, SURESNES; (3) Diocèse de Pharmacovigilance, Lilly France, SURESNES;
Aposter Mercredi 16/04   16  P189 K Lacut (1); E Oger (1); G Le Gal (1); F Couturaud (1); S Pépite (2); C Leroyer (1); D Mottier (1); STATIN USE IS ASSOCIATED WITH A REDUCED RISK FOR VENOUS THROMBOEMBOLISM
Abstract comble
(1) Diocèse de Allopathie Dedans et Phtisiologie, CHU Mulassière Terreuse, BREST; (2) Conformité d’Echo-Doppler, CHU Mulassière Terreuse, BREST;
Aposter Mercredi 16/04   16  P190 S Dias (1); M Cucherat (1); E Amsallem (1); JP Boissel (1); ACCEPTABILITY BY GPS OF A NEW APPROACH OF KNOWLEDGE TRANSFER IN THERAPEUTICS
Abstract comble
(1) EA 643, Institut de allopathie RTH Laennec, LYON;
Aposter Mercredi 16/04   16  P191 M Daurel-Responsable (1); S Picard (1); K Titier (1); D Ducint (1); F Pehourcq (1); N Moore (1); M Molimard (1); FULLY AUTOMATED ANALYTICAL METHOD FOR MYCOPHENOLIC ACID QUANTIFICATION IN HUMAN PLASMA USING ON-LINE SOLID PHASE EXTRACTION AND HIGH PERFORMANCE LIQUID CHROMATOGRAPHY WITH ULTRAVIOLET DETECTION
Abstract comble
(1) Cabinet de pharmacologie asile et de toxicologie, Internat V. Segalen, CHU Pellegrin, BORDEAUX;
Aposter Mercredi 16/04   16  P192 M Cucherat (1); E Amsallem (1); JP Boissel (1); TRIALYS : A KNOWLEDGE DATABASE OF CLINICAL TRIALS RESULTS
Abstract comble
(1) EA 643, Institut de Allopathie Laennec, LYON;
Aposter Mercredi 16/04   16  P193 S Belgun – florea (1); S Briançon (2); J Doury (1); H Fessi (2); DEVELOPMENT OF A NEW PHARMACEUTICAL FORMULATION EFFECTIVE IN PREVENTION AND/OR TREATMENT OF DENTO-PERIODONTAL DISEASES
Abstract comble
(1) Cabinet de élaboré en trempe ouverte (Lass – UMR 5823 CNRS), Institut d’stomatologie, 11 rue Guimbarde Parradin, LYON; (2) Cabinet d’Involontaire et de Aptitude des Procédés (Lagep-UMR 5007CNRS), Univ. C. Bernard Lyon1, 43 bd du 11 brumaire 1918, VILLEURBANNE;
Aposter Mercredi 16/04   16  P194 AN Barkun (1); V Adam (2); W Kennedy (3); CA Fallone (1); K Herba (1); M Bardou (1); THE COST-EFFECTIVENESS OF HIGH DOSE ORAL VERSUS INTRAVENOUS PROTON PUMP INHIBITION IN HIGH-RISK PATIENTS WITH BLEEDING PEPTIC ULCERS HAVING UNDERGONE THERAPEUTIC ENDOSCOPY
Abstract comble
(1) Gastroenterology Department, McGill University Health Center, MONTREAL, CANADA; (2) Fragment of epidemiology, McGill University, MONTREAL, CANADA; (3) Institut de ampoule, Internat de Montréal, MONTREAL, CANADA;
Aposter Mercredi 16/04   16  P195 P Nicolas (1); B Uzzan (1); M Cucherat (2); JP Boissel (2); GY Perret (1); THE ROLE OF MICROVESSEL DENSITY (MVD) ON THE SURVIVAL OF PATIENTS WITH BREAST CARCINOMA : A SYSTEMATIC REVIEW OF THE LITERATURE WITH META-ANALYSIS
Abstract comble
(1) Lab Pharmacologie, Institut de Allopathie – CHU Bobigny, BOBIGNY; (2) Lab Pharmacologie, Institut de Allopathie – Internat Lyon 1, LYON;
Aposter Mercredi 16/04   17  P196 S Oger (1); C Mehats (2); E Dallot (1); F Protégé (1); D Cabrol (1); MJ Leroy (1); UTERO-RELAXANT AND ANTI-INFLAMMATORY PROPERTIES OF SELECTIVE PDE4 (cAMP-SPECIFIC PHOSPHODIESTERASES) INHIBITORS IN HUMAN MYOMETRIUM
Abstract comble
(1) INSERM U361, Procréation Arrivage Princier Cochin, Internat Paris 5, PARIS; (2) Fragment of Reproductive Biology, Stanford University School of Medicine, STANFORD, ETATS-UNIS;
Aposter Mercredi 16/04   17  P197 C Vendangeon (1); MJ Leroy (2); M Breuiller-Fouché (2); C Loustalot (3); E Morcillo (4); T Croci (5); E Naline (1); F Protégé (2); C Advenier (1); M Bardou (1); ABSENCE OF DESENSITISATION OF BETA 3 ADRENERGIC RESPONSE IN HUMAN NEAR-TERM MYOMETRIUM
Abstract comble
(1) UPRES EA220, UFR Biomédicale des Saints Pères, PARIS; (2) INSERM U361, Villa Baudelocque, PARIS; (3) CHU du Buisson, Dijon, DIJON; (4) Diocèse de Pharmacologie, Internat de Valence, VALENCE, ESPAGNE; (5) Épicentre de élaboré Sanofi-Midy, Milan, MILAN, ITALIE;
Aposter Mercredi 16/04   17  P198 N Geffroy (1); A Guédin (1); P Formstecher (1); C Dacquet (2); P Lefebvre (1); CHARACTERIZATION OF NON GENOMIC EFFECTS OF ESTROGENS IN HELA AND MCF7 CELLS
Abstract comble
(1) INSERM U459, Institut de Allopathie H Warembourg, LILLE; (2) Institution de Recherches Servier, IRIS, COURBEVOIE;
Aposter Mercredi 16/04   17  P199 M Sarr (1); JC Alencar (1); JC Stoclet (1); VB Schini-Kerth (1); B Muller (2); LONG-LASTING INHIBITION OF ARTERIAL TONE BY NO IN VARIOUS VASCULAR BEDS: DIFFERENTIAL INFLUENCE OF THE ENDOTHELIUM
Abstract comble
(1) UMR 7034, Institut de Ampoule, STRASBOURG; (2) INSERM 9937, UFR Sciences Pharmaceutiques & EMI, BORDEAUX;
Aposter Mercredi 16/04   17  P200 K Père (1); N Simon (1); B Bruguerolle (1); EFFECTS OF CHLORPYRIFOS ON OXIDATIVE PHOSPHORYLATION OF ISOLATED RAT MITOCHONDRIA
Abstract comble
(1) Cabinet de Pharmacologie médicale et asile, Institut de allopathie, MARSEILLE;
Aposter Mercredi 16/04   17  P201 B Guillet (1); L Velly (1); S Lortet (2); F Masmejean (2); A Nieoullon (2); P Pisano (1); REGULATION OF ACTIVITY AND CELL SURFACE EXPRESSION OF GLUTAMATE TRANSPORTERS IN NEURON-ENRICHED CULTURES REQUIRES PHOSPHORYLATION
Abstract comble
(1) Cabinet de pharmacodynamie, UFR Ampoule, 27 bd Pantalon Cellier, MARSEILLE; (2) LNCF, FRE CNRS 2131, 31 Berme Joseph Aiguier, MARSEILLE;
Aposter Mercredi 16/04   17  P202 L Favot (1); T Keravis (1); V Holl (2); C Lugnier (1); INVOLVEMENT OF CYCLIC NUCLEOTIDE PHOSPHODIESTERASES (PDES) IN ANGIOGENESIS
Abstract comble
(1) UMR CNRS 7034, Institut de ampoule, ILLKIRCH; (2) Cabinet de Oncologie Expérimentale et de Radiobiologie (LCER), IRCAD, STRASBOURG;
Aposter Mercredi 16/04   17  P203 A Maguy (1); D Godreau (1); R Vranckx (1); C Goyenvalle (1); S Hatem (1); SAP-97 PROMOTES HKV1.5 COMPARTMENTATION TO LIPID RAFTS AND INTERACTION WITH BETA-SUBUNIT: CONSEQUENCES ON CURRENTS PROPERTIES
Abstract comble
(1) U460 INSERM, Institut de allopathie X. BICHAT, PARIS;
Aposter Mercredi 16/04   17  P204 A Maguy (1); S Hatem (1); D Godreau (1); NEW PROCEDURE TO REALISE CELL LINE STABLY EXPRESSING A CLONED PROTEIN
Abstract comble
(1) U460 INSERM, Institut de allopathie X. BICHAT, PARIS;
Aposter Mercredi 16/04   17  P205 C Moro (1); J Galitzky (1); C Sengenès (1); F Crampes (1); M Lafontan (1); M Berlan (1); EVALUATION OF ANP-INDUCED LIPOLYSIS ANTAGONISTS IN HUMAN ADIPOSE TISSUE.
Abstract comble
(1) INSERM U317, Institut de Allopathie, TOULOUSE;
Aposter Mercredi 16/04   17  P206 C Labrande (1); F Masmejean (2); S Lortet (2); A Nieoullon (2); P Pisano (1); NEUROPROTECTIVE EFFECTS OF TACROLIMUS DURING IN VITRO CEREBRAL ISCHEMIA : INSIGHTS ON THE ROLE OF GLUTAMATE
Abstract comble
(1) Cabinet pharmacodynamie, Institut Ampoule 27 bd Pantalon Cellier, MARSEILLE; (2) FRE CNRS 2131, 31 Berme Joseph Aiguier, MARSEILLE;
Aposter Mercredi 16/04   18  P207 C Brefel-Courbon (1); P Payoux (2); C Thalamas (3); I Quelven (2); M Galitzky (3); JL Montastruc (1); JP Esquerre (2); F Chollet (4); O Rascol (1); LEVODOPA EFFECT ON EXPERIMENTAL PAIN IN PARKINSON’S DISEASE: A CLINICAL AND NEUROIMAGING PILOT STUDY
Abstract comble
(1) Largesse de Pharmacologie, INSERM U455, Institut de Allopathie, TOULOUSE; (2) Largesse de medecine atomique INSERM U455, CHU Purpan, TOULOUSE; (3) Épicentre d’sondage asile, CHU Purpan, TOULOUSE; (4) INSERM U455, CHU Purpan, TOULOUSE;
Aposter Mercredi 16/04   18  P208 J Micallef (1); S Tardieu (1); S Durand (1); G Masson (2); D Mestre (2); O Blin (1); EFFECTS OF A SUBANESTHETIC DOSE OF KETAMINE ON SACCADIC EYE MOVEMENTS IN HEALTHY SUBJECTS
Abstract comble
(1) CPCET & Institution de Neurosciences Physiologiques et Cognitives, CHU Timone, MARSEILLE; (2) Épicentre de Recherches en Neurosciences Cognitives, CNRS, MARSEILLE;
Aposter Mercredi 16/04   18  P209 O Rascol (1); D Brooks (2); W Olanow (3); G Koch (4); PH Truffinet (5); R Bejuit (5); The Riluzole 320 Study Group (6); THE EFFECT OF RILUZOLE ON PARKINSON’S DISEASE PROGRESSION : A 2-YEAR TRIAL
Abstract comble
(1) Largesse de Pharmacologie, INSERM U455, Institut de Allopathie, TOULOUSE; (2) Hammersmith Hospital, MRC Bêtatron Unit, LONDON, UK; (3) Mount Sinai, Medical Center, NEW YORK, USA; (4) Biostatistics Department, Chapel Hill, CHAPEL HILL, USA; (5) Aventis, ANTONY; (6) 122 Investigators from eleven countries, INTERNATIONAL;
Aposter Mercredi 16/04   18  P210 H Allain (1); D Bentue-Appâter (1); A Tarral (2); O Impôt (1); E Polard (3); JM Gandon (2); EFFECTS ON POSTURAL OSCILLATION AND MEMORY FUNCTIONS OF A SINGLE DOSE OF ZOLPIDEM 5MG, ZOPICLONE 3.75MG AND LORMETAZEPAM 1MG IN ELDERLY HEALTHY SUBJECTS
Abstract comble
(1) Cabinet de Pharmacologie Expérimentale et Maternité, Institut de Allopathie, RENNES; (2) BIOTRIAL S.A., Atalante Villejean, RENNES; (3) Épicentre de Pharmacovigilance, Hosto Pontchaillou, RENNES;
Aposter Mercredi 16/04   18  P211 G Pickering (1); V Batel (1); A Eschalier (1); C Dubray (1); ANALGESICS CONSUMPTION AND ALZHEIMER’S DISEASE
Abstract comble
(1) INSERM EMI 9904 Cabinet de Pharmacologie Médicale, Institut de Allopathie BP38 CHU, CLERMONT-FERRAND;
Aposter Mercredi 16/04   19  P212 C Sévoz-Protection (1); MA Comet (1); M Hamon (1); R Laguzzi (1); INVOLVEMENT OF NUCLEUS TRACTUS SOLITARIUS (NTS) 5-HT3 AND GABAA RECEPTORS IN THE DEFENSE REACTION-INDUCED INHIBITION OF AORTIC BAROREFLEX BRADYCARDIA IN THE RAT
Abstract comble
(1) INSERM U288, Institut de allopathie Offrande-Salpêtrière, PARIS;
Aposter Mercredi 16/04   19  P213 A Kreisler (1); P Glacial (2); A Destée (1); R Bordet (2); NEUROPROTECTIVE EFFECT OF PPAR-ALPHA AGONIST IN THE MPTP MOUSE MODEL OF PARKINSON’S DISEASE
Abstract comble
(1) EA 2643, Neurologie A, CHRU, LILLE; (2) EA 1046, Pharmacologie, Institut de Allopathie, LILLE;
Aposter Mercredi 16/04   19  P215 V Lelong (1); F Héritier (2); M Boulouard (1); LOCALIZATION OF 5-HT4 RECEPTORS IMPLICATED IN WORKING MEMORY IN MICE: EFFECT OF SEROTONERGIC LESIONS ON BEHAVIOURAL AND NEUROCHEMICAL (BINDING SITES DENSITY) PARAMETERS
Abstract comble
(1) UPRES EA 2126, Institut de Ampoule, Internat de Caen, CAEN; (2) UMR 6551, Internat de Caen, CAEN;
Aposter Mercredi 16/04   19  P216 H Legros (1); F Janin (1); N Dourmap (1); JJ Béguin (1); J Costentin (1); SEMI-CHRONIC INCREASE IN STRIATAL LEVEL OF 3,4-DIHYDROXYPHENYLACETALDEHYDE DOES NOT RESULT IN ALTERATION OF NIGRO-STRIATAL DOPAMINERGIC NEURONS
Abstract comble
(1) Conformité de NeuroPsychoPharmacologie Expérimentale UMR 6036 CNRS, Institut de Allopathie et de Ampoule, ROUEN;
Aposter Mercredi 16/04   19  P217 P Bredeloux (1); A Tabarly (1); I Dubuc (1); J Martinez (2); J Costentin (1); MICE MADE TOLERANT TO MORPHINE ANALGESIA ARE ALSO TOLERANT TO THE ANALGESIC EFFECT OF A CYCLIC ANALOG OF NEUROTENSIN
Abstract comble
(1) UMR 6036 CNRS, Conformité de neuropsychopharmacologie expérimentale, IFRMP23, Institut de Allopathie et de Ampoule, ROUEN; (2) Cabinet des Aminoacides, peptides et protéines ESA 5075, Institut de ampoule, MONTPELLIER;
Aposter Mercredi 16/04   19  P218 MA Comet (1); C Sévoz-Protection (1); M Hamon (1); R Laguzzi (1); ACTIVATION OF THE PERIAQUEDUCTAL GRAY MATTER INHIBITS THE CARDIAC COMPONENT OF THE BARORECEPTOR REFLEX VIA STIMULATION OF 5-HT3 RECEPTORS IN THE RAT NUCLEUS TRACTUS SOLITARIUS
Abstract comble
(1) INSERM U288, Institut de allopathie Offrande-Salpêtrière, PARIS;
Aposter Mercredi 16/04   19  P219 JP Guilloux (1); C Przybylski (1); F Artigas (2); M Toth (3); AM Gardier (1); EFFECT OF COADMINISTRATION OF PAROXETINE AND (±)-PINDOLOL ON EXTRACELLULAR SEROTONIN : A NOVEL APPROACH USING KO 5-HT1A MICE
Abstract comble
(1) EA 3544 Lab. Neuropharmacologie, Institut de Ampoule Internat Paris-Sud, CHATENAY-MALABRY; (2) Departement of Neurochemistry, Institution d’Investigacions Biomediques, BARCELONA, SPAIN; (3) Department of pharmacology, Weill Medical College of Cornell University, NEW YORK, USA;
Aposter Mercredi 16/04   19  P220 J Giletier (1); N Croci (1); M Plotkine (1); I Margaill (1); 3-AMINOBENZAMIDE, A POLY(ADP-RIBOSE) POLYMERASE INHIBITOR, REDUCES BRAIN INFARCTION AND POLYMORPHONUCLEAR NEUTROPHIL INFILTRATION AFTER CEREBRAL ISCHEMIA/REPERFUSION IN MICE
Abstract comble
(1) Cabinet de Pharmacologie UPRES EA2510, Internat René Descartes Paris V, PARIS;

Feuillet précédente